CD8A and neoplasm: Met@Man-MPs can effectively improve the tumor immune microenvironment by promoting the recruitment of CD8+ T cells using cytokines such as TNF-α secreted by their polarization into M1-type TAMs and reducing the number of MDSCs and Tregs.